Amphastar Pharmaceuticals Stock Price

-0.57 (-2.96%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.57 -2.96% 18.69 19:53:21
Open Price Low Price High Price Close Price Prev Close
19.22 18.67 19.4484 18.69 19.26
Bid Price Ask Price Spread News
18.34 18.78 0.44 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,478 155,294 $ 18.96 $ 2,944,818 225,220 12.325 - 22.70
Last Trade Time Type Quantity Stock Price Currency
19:09:19 4 $ 18.88 USD

Amphastar Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 887.85M 47.50M 30.28M $ 322.36M $ 8.74M 0.99 142.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -1.50k 2.20%

more financials information »

Amphastar Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.0220.0018.6719.60178,047-0.33-1.74%
1 Month18.2820.9318.2019.58219,9110.412.24%
3 Months20.7421.3317.5119.17206,498-2.05-9.88%
6 Months20.7221.44517.5119.65200,487-2.03-9.8%
1 Year19.0722.7012.32518.65248,298-0.38-1.99%
3 Years18.5325.4312.32519.23213,2050.160.86%
5 Years12.1025.4310.5018.07247,8526.5954.46%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, lidocaine, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API. Its products are used in hospitals or urgent care clinical settings. Geographically the business presence of the firm is seen in the United States and France of which the US accounts for the majority of revenue.

Your Recent History
Amphastar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.